| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 22.64B | 25.76B | 22.90B | 31.38B | 39.90B |
| Gross Profit | 1.30B | 2.35B | 2.45B | 9.88B | 12.52B |
| EBITDA | -220.05M | 545.06M | -538.26M | 7.27B | 9.27B |
| Net Income | -5.89B | -5.77B | -2.59B | 445.75M | 6.03B |
Balance Sheet | |||||
| Total Assets | 168.61B | 192.02B | 214.81B | 233.75B | 245.06B |
| Cash, Cash Equivalents and Short-Term Investments | 7.25B | 6.11B | 7.85B | 9.73B | 19.60B |
| Total Debt | 55.83B | 58.97B | 61.68B | 65.87B | 75.50B |
| Total Liabilities | 128.44B | 142.62B | 159.49B | 171.15B | 182.65B |
| Stockholders Equity | 26.74B | 33.04B | 37.59B | 41.63B | 41.21B |
Cash Flow | |||||
| Free Cash Flow | 2.88B | 1.54B | 5.06B | 4.07B | 1.48B |
| Operating Cash Flow | 3.01B | 1.71B | 5.56B | 4.44B | 1.94B |
| Investing Cash Flow | 672.44M | -274.89M | 3.91B | -1.65B | -22.86B |
| Financing Cash Flow | -4.41B | -3.07B | -11.32B | -12.55B | 15.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
45 Neutral | HK$960.57M | -0.16 | -20.57% | ― | -12.18% | -2.23% | |
44 Neutral | HK$1.27B | 0.07 | ― | ― | -52.61% | ― | |
44 Neutral | HK$1.46B | -0.18 | -67.24% | ― | -49.30% | -54.16% | |
43 Neutral | HK$755.69M | 0.01 | ― | ― | -17.69% | ― | |
42 Neutral | HK$1.15B | -0.05 | -158.53% | ― | -35.92% | -31.49% | |
39 Underperform | HK$1.44B | -0.10 | -89.23% | ― | -34.82% | 6.82% |